Impaired Callus Formation in Pathological Mandibular Fractures in Medication-Related Osteonecrosis of the Jaw and Osteoradionecrosis
- PMID: 34097863
- DOI: 10.1016/j.joms.2021.04.024
Impaired Callus Formation in Pathological Mandibular Fractures in Medication-Related Osteonecrosis of the Jaw and Osteoradionecrosis
Abstract
Purpose: Nonsurgical treatment of mandibular fractures secondary to medication-related osteonecrosis of the jaw (MRONJ) or osteoradionecrosis (ORN) mostly results in nonunion, whereas nonsurgical fracture treatment of atrophic fractures can achieve favorable results in selected cases. The aim of this study was to compare callus formation in pathological mandibular fractures due to MRONJ, ORN, or extreme mandibular atrophy.
Methods: A retrospective cohort study reviewing the medical records of all MRONJ-, ORN-, or atrophy-related fractures treated at the departments of maxillofacial surgery in the Leuven or Lille university hospitals between 2010 and 2019 was undertaken. The primary predictor variable in this study was disease state (MRONJ, ORN, or extreme mandibular atrophy). The primary outcome variable was callus formation after 1 month of follow-up (present, absent). Additional study variables measured included patient age and gender. T-tests, Fisher exact tests, and multiple logistic regression were used for statistical analysis. The significance level was set at P < .05.
Results: Seventy patients were analyzed (12 MRONJ cases, 54 ORN fractures, 4 atrophic fractures). The callus formation prevalence in nonsurgically approached fractures secondary to ORN and MRONJ after 1 month of follow-up was 3.03% (2/66 cases). In contrast, callus was detected in all patients in the mandibular atrophy-related fracture group. Osteonecrosis was statistically correlated with impaired callus formation (P = .0121).
Conclusion: Whereas one would expect indirect fracture healing and thus callus formation to occur in all non-surgically treated fractures, our data demonstrate its absence in the majority of MRONJ- and ORN-related fractures. Multiple plausible explanations for this phenomenon were identified: periosteal damage with loss of callus-forming cells, compromised vasculature, and bacterial colonization.
Copyright © 2021 The American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Osteoradionecrosis and medication-related osteonecrosis of the jaw: similarities and differences.Int J Oral Maxillofac Surg. 2016 Dec;45(12):1592-1599. doi: 10.1016/j.ijom.2016.06.016. Epub 2016 Jul 15. Int J Oral Maxillofac Surg. 2016. PMID: 27427547
-
Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw.Oral Maxillofac Surg. 2018 Mar;22(1):59-63. doi: 10.1007/s10006-017-0667-5. Epub 2017 Dec 9. Oral Maxillofac Surg. 2018. PMID: 29224060
-
Antiresorptive therapy in combination with radiation results in enhanced risk for necrosis and associated complicatifions.Oral Surg Oral Med Oral Pathol Oral Radiol. 2025 Jan;139(1):11-19. doi: 10.1016/j.oooo.2024.07.008. Epub 2024 Aug 9. Oral Surg Oral Med Oral Pathol Oral Radiol. 2025. PMID: 39472248
-
Medication-related osteonecrosis and osteoradionecrosis of the jaws: Update and current management.Morphologie. 2021 Jun;105(349):170-187. doi: 10.1016/j.morpho.2020.11.008. Epub 2020 Dec 3. Morphologie. 2021. PMID: 33281055 Review.
-
Is there a role for pentoxifylline and tocopherol in the management of advanced osteoradionecrosis of the jaws with pathological fractures? Case reports and review of the literature.Int J Oral Maxillofac Surg. 2019 Aug;48(8):1022-1027. doi: 10.1016/j.ijom.2019.03.894. Epub 2019 Apr 10. Int J Oral Maxillofac Surg. 2019. PMID: 30981534 Review.
Cited by
-
Pathological Fractures of the Mandible: Our Department's 15-Year Experience.Diagnostics (Basel). 2025 May 12;15(10):1216. doi: 10.3390/diagnostics15101216. Diagnostics (Basel). 2025. PMID: 40428209 Free PMC article.
-
Enhancer-driven Shh signaling promotes glia-to-mesenchyme transition during bone repair.Bone Res. 2025 Jan 26;13(1):16. doi: 10.1038/s41413-024-00396-8. Bone Res. 2025. PMID: 39865079 Free PMC article.
-
Immune microenvironment: novel perspectives on bone regeneration disorder in osteoradionecrosis of the jaws.Cell Tissue Res. 2023 May;392(2):413-430. doi: 10.1007/s00441-023-03743-z. Epub 2023 Feb 4. Cell Tissue Res. 2023. PMID: 36737519 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical